Blue Investment Partners’s AbbVie ABBV Stock Holding History

Blue Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$383K	Hold	2,061	–	–	0.13%	34
2025 Q1	$432K	Hold	2,061	–	–	0.16%	34
2024 Q4	$366K	Buy	2,061 +500	+32%	+$91.9K	0.13%	37
2024 Q3	$308K	Hold	1,561	–	–	0.13%	37
2024 Q2	$268K	Hold	1,561	–	–	0.12%	39
2024 Q1	$284K	Hold	1,561	–	–	0.15%	34
2023 Q4	$242K	Sell	1,561 -103	-6%	-$15K	0.16%	31
2023 Q3	$248K	Buy	1,664 +103	+7%	+$15.1K	0.2%	27
2023 Q2	$210K	Hold	1,561	–	–	0.16%	28
2023 Q1	$249K	Sell	1,561 -135	-8%	-$20.6K	0.25%	25
2022 Q4	$274K	Buy	+1,696	New	+$260K	0.34%	22

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Blue Investment Partners's ABBV Position: Q2 2025 in Review

Blue Investment Partners held its AbbVie (ABBV) position steady in Q2 2025 at 2,061 shares worth $383K. The position accounts for 0.13% of the portfolio, ranked #34.

Blue Investment Partners first reported a position in ABBV in Q4 2022 and has held it in 11 quarters since. The position peaked at $432K in Q1 2025. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Blue Investment Partners held 2,061 shares of AbbVie worth $383K as of Q2 2025.
Blue Investment Partners left its AbbVie share count unchanged in Q2 2025.
AbbVie made up 0.13% of Blue Investment Partners's portfolio in Q2 2025, its #34 holding.
Blue Investment Partners first reported a position in AbbVie in Q4 2022 and has held it in 11 quarters since.
Blue Investment Partners's AbbVie position peaked at $432K in Q1 2025.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Blue Investment Partners's 13F filing for Q2 2025, filed 6 Aug 2025.